#genetic testing

#genetic testing

The main award went to Yvonne Lundberg Giwercman, a professor at Lund University's Faculty of Medicine, for developing a patient-specific IVF test that significantly improves fertility treatment outcomes. The test analyzes genetic data to tailor hormone therapies for individual patients-a capability that doesn't exist today. "Research shows that women receiving genetically adapted hormone therapy have a 38% higher chance of having a baby compared to those who don't," said Lundberg Giwercman. The innovation could make IVF treatments more effective and accessible for countless couples struggling with infertility.

People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer's by age 85. Only about 2% to 3% of people in the U.S. have this genetic profile, and most of them don't know it because they've never sought genetic testing. But three scientists are among those who did get tested, and learned that they are in the high-risk group.

"It takes me back to the 1950s and 1960s, when women practically had to go through a series of controls, had to undress in front of a panel of doctors," she told DW. "I get the impression that we haven't advanced from a scientific point of view. We've made practically no progress if it's now categorically said that women with X and Y chromosomes are not women."

Regeneron's acquisition is aimed at enhancing 23andMe's mission of helping individuals understand their DNA, while ensuring compliance with privacy protocols.

This week’s episode kicks off with a powerful story about an influencer who discovered his cancer through his baby's genetic testing, highlighting the unforeseen impacts of genetic health information.